See other companies on Welcome to the Jungle
Caresyntax
Making surgery smarter, safer, and more profitable
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- SaaS
- Data Analysis
- Automation
- MedTech
- Prudential / St. Botolph, Boston, MA
Jump to section
Company mission
To make surgery safer and smarter by empowering healthcare providers, insurers, and medical technology companies with innovative, data-driven solutions.
1% employee growth in 12 months
Our take
Caresyntax is the leading surgical data platform that enables OR teams to predict and improve surgical performance, its proprietary software and AI technology analyze large volumes of video, audio, images, device data, and clinical and operational data in and around the operating room. This provides real-world evidence that supports care teams during and following surgery.
The company’s range of insights benefits surgeons, hospital administrators, medical device companies, and insurance companies – improving care, efficacy, product advancement, and understanding. Its software is used in more than 4,000 operating rooms around the globe, supporting more than 30,000 surgeons and over 2 million procedures per year.
With a number of strategic partnerships – including with Intel and Google Cloud – and receiving several global awards and recognitions, the company saw accelerated growth over the course of 2022, which will help fuel the development of new capabilities and the formation of new partnerships, Caresyntax furthers its global expansion efforts.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Flexible Working Hours
- Learning management tools
- Work visa sponsorship and relocation assistance (where applicable)
- Registration to Headspace
- Hybrid & Remote Work Opportunities
Company values
- Ownership - A personal commitment to take initiative and follow through on your responsibilities
- Integrity - Doing the right thing, even when it is difficult
- Knowledge: - Embracing learning and analysis to support data-driven decision-making and foster personal growth
- Innovation - A pioneering mindset and approach – combining imagination, information and initiative to solve business and market challenges
Funding (last 2 of 6 rounds)
Aug 2024
$80m
SERIES C
Sep 2021
$30m
SERIES C
Total funding: $299.4m
This company has top investors
Leadership
Dennis Kogan
(CEO)In addition to their current position, they are also a Managing Partner of surgical.ai.
Bjoern von Siemens
(CFO)In addition to their current position, they are also a Managing Partner of surgical.ai. Has worked for various Healthcare companies, including Boston Consulting Group and Bain & Co.